Cargando…

Challenges and issues of SARS-CoV-2 pool testing

Detalles Bibliográficos
Autores principales:	Eberhardt, Jens N, Breuckmann, Nikolas P, Eberhardt, Christiane S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832072/ https://www.ncbi.nlm.nih.gov/pubmed/32679088 http://dx.doi.org/10.1016/S1473-3099(20)30467-9

Ejemplares similares

Challenges and issues of SARS-CoV-2 pool testing
por: Lee, Jaehyeon, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing
por: Mishra, Baijayantimala, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing – Authors' reply
por: Lohse, Stefan, et al.
Publicado: (2020)

Pooling of samples for testing for SARS-CoV-2 in asymptomatic people
por: Lohse, Stefan, et al.
Publicado: (2020)

Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening
por: Eberhardt, J.N., et al.
Publicado: (2020)

Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
por: Mamez, Anne-Claire, et al.
Publicado: (2021)

Pooled saliva samples as an approach to reduce the spread of infections with SARS-CoV-2
por: Möst, Johannes, et al.
Publicado: (2021)

Evaluation of SARS CoV-2 RT-PCR in a multiple sample pool
por: Garg, Jaya, et al.
Publicado: (2021)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products
por: Romero, Carolina, et al.
Publicado: (2021)

Validation of specimen pooling using the Cepheid Xpert Xpress SARS-CoV-2 assay
por: Balgahom, Rifky, et al.
Publicado: (2022)

Challenges of managing the asymptomatic carriers of SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products—an update
por: Romero, Carolina, et al.
Publicado: (2022)

Testing for responses to the wrong SARS-CoV-2 antigen?
por: Rosadas, Carolina, et al.
Publicado: (2020)

SARS-CoV-2 rapid antigen detection tests
por: Weitzel, Thomas, et al.
Publicado: (2021)

SARS-CoV-2 rapid antigen detection tests
por: Fouzas, Sotirios
Publicado: (2021)

Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing
por: Joung, Julia, et al.
Publicado: (2020)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Positive tracheal SARS-CoV-2 RNA test after three negative SARS-CoV-2 RNA tests in a patient with COVID-19
por: Vigneshwar, Navin G., et al.
Publicado: (2020)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Challenges in interpreting SARS-CoV-2 serological results in African countries
por: Nkuba Ndaye, Antoine, et al.
Publicado: (2021)

SARS-CoV-2 rapid diagnostic tests for emerging variants
por: Bekliz, Meriem, et al.
Publicado: (2021)

Multiple testing and the effect of NPIs on the spread of SARS-CoV-2
por: Rothe, Christoph
Publicado: (2021)

Cadaveric donor specimens and serological testing for SARS-CoV-2
por: Yeang, Malinna, et al.
Publicado: (2022)

Considerations for Pooled Testing of Employees for SARS-CoV-2
por: Schulte, Paul A., et al.
Publicado: (2021)

Pooled Saliva Specimens for SARS-CoV-2 Testing
por: Barat, Bidisha, et al.
Publicado: (2020)

Pooled Saliva Specimens for SARS-CoV-2 Testing
por: Barat, Bidisha, et al.
Publicado: (2021)

Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2
por: Pfaff, Florian, et al.
Publicado: (2022)

Cardiovascular disorders followed by SARS-CoV-2 infection: An inevitable challenge – Correspondence()
por: Rouhani, Jalil, et al.
Publicado: (2022)

Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
por: Pallett, Scott J C, et al.
Publicado: (2021)

Is oropharyngeal sampling a reliable test to detect SARS-CoV-2?
por: Todsen, Tobias, et al.
Publicado: (2021)

SARS-CoV-2 antigen-detecting rapid tests for the delta variant
por: Bekliz, Meriem, et al.
Publicado: (2022)

SARS-CoV-2 rapid antigen detection tests – Authors' reply
por: Peeling, Rosanna W, et al.
Publicado: (2021)

Ignoring SARS-CoV-2 testing performance during COVID-19
por: Buchta, Christoph, et al.
Publicado: (2023)

Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
por: Wang, Pei-Gang, et al.
Publicado: (2020)

SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability
por: Foster, Charles S.P., et al.
Publicado: (2022)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Pooling Samples to Increase SARS-CoV-2 Testing
por: Gopalkrishnan, Manoj, et al.
Publicado: (2020)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

SARS-CoV-2 incidence and vaccine escape
por: Thompson, Robin N, et al.
Publicado: (2021)

SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects – correspondence
por: Channabasappa, Nikhil K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0hvnvdrmido2sfo5gho4nbsif7